A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Terns Pharmaceuticals, Inc. stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 2,707,515 shares of TERN stock, worth $15.7 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
2,707,515
Previous 2,690,376 0.64%
Holding current value
$15.7 Million
Previous $18.3 Million 23.25%
% of portfolio
0.06%
Previous 0.05%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$6.49 - $10.8 $111,232 - $185,101
17,139 Added 0.64%
2,707,515 $22.6 Million
Q2 2024

Aug 14, 2024

BUY
$4.54 - $8.2 $2.13 Million - $3.85 Million
469,176 Added 21.12%
2,690,376 $18.3 Million
Q1 2024

May 15, 2024

BUY
$4.86 - $8.19 $10.8 Million - $18.2 Million
2,221,200 New
2,221,200 $14.6 Million
Q3 2023

Nov 14, 2023

BUY
$4.7 - $8.55 $2.68 Million - $4.88 Million
571,265 New
571,265 $2.87 Million
Q1 2023

May 15, 2023

BUY
$7.91 - $12.0 $3.13 Million - $4.75 Million
395,598 Added 169.42%
629,098 $7.45 Million
Q4 2022

Feb 14, 2023

BUY
$4.62 - $10.18 $1.08 Million - $2.38 Million
233,500 New
233,500 $2.38 Million
Q2 2022

Aug 15, 2022

BUY
$1.5 - $3.0 $566,140 - $1.13 Million
377,427 Added 307.92%
500,000 $1.24 Million
Q1 2022

May 16, 2022

BUY
$2.83 - $6.7 $346,881 - $821,239
122,573 New
122,573 $364,000

Others Institutions Holding TERN

About Terns Pharmaceuticals, Inc.


  • Ticker TERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,613,800
  • Market Cap $218M
  • Description
  • Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis (NASH) and obesity. The company develops TERN-101, a liver-distributed and non-bile acid farnesoid X receptor agonist, which is in Phase IIa clinical t...
More about TERN
Track Steven Cohen's Portfolio

Track Steven Cohen Portfolio

Follow Steven Cohen (Point72 Asset Management, L.P.) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.